» Articles » PMID: 24083410

Photouncaging Nanoparticles for MRI and Fluorescence Imaging in Vitro and in Vivo

Overview
Journal ACS Nano
Specialty Biotechnology
Date 2013 Oct 3
PMID 24083410
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Multimodal and multifunctional nanomaterials are promising candidates for bioimaging and therapeutic applications in the nanomedicine settings. Here we report the preparation of photouncaging nanoparticles with fluorescence and magnetic modalities and evaluation of their potentials for in vitro and in vivo bioimaging. Photoactivation of such bimodal nanoparticles prepared using photouncaging ligands, CdSe/ZnS quantum dots, and super paramagnetic iron oxide nanoparticles results in the systematic uncaging of the particles, which is correlated with continuous changes in the absorption, mass and NMR spectra of the ligands. Fluorescence and magnetic components of the bimodal nanoparticles are characterized using scanning electron microscopy (SEM), transmission electron microscopy (TEM), and elemental analyses using energy dispersive X-ray (EDX) spectroscopy and X-ray photoelectron spectroscopy (XPS). Bioconjugation of the nanoparticles with peptide hormones renders them with biocompatibility and efficient intracellular transport as seen in the fluorescence and MRI images of mouse melanoma cells (B16) or human lung epithelial adenocarcinoma cells (H1650). Biocompatibility of the nanoparticles is evaluated using MTT cytotoxicity assays, which show cell viability over 90%. Further, we combine MRI and NIR fluorescence imaging in C57BL/6 (B6) mice subcutaneously or intravenously injected with the photouncaging nanoparticles and follow the in vivo fate of the nanoparticles. Interestingly, the intravenously injected nanoparticles initially accumulate in the liver within 30 min post injection and subsequently clear by the renal excretion within 48 h as seen in the time-dependent MRI and fluorescence images of the liver, urinary bladder, and urine samples. Photouncaging ligands such as the ones reported in this article are promising candidates for not only the site-specific delivery of nanomaterials-based contrast agents and drugs but also the systematic uncaging and renal clearance of nanomaterials after the desired in vivo application.

Citing Articles

Approaches to Nanoparticle Labeling: A Review of Fluorescent, Radiological, and Metallic Techniques.

Chen H, Hu Q, Li W, Cai X, Mao L, Li R Environ Health (Wash). 2024; 1(2):75-89.

PMID: 39473584 PMC: 11504608. DOI: 10.1021/envhealth.3c00034.


Integrated insulin-iron nanoparticles: a multi-modal approach for receptor-specific bioimaging, reactive oxygen species scavenging, and wound healing.

Attri K, Chudasama B, Mahajan R, Choudhury D Discov Nano. 2024; 19(1):96.

PMID: 38814485 PMC: 11139842. DOI: 10.1186/s11671-024-04024-6.


Photosensitizer-singlet oxygen sensor conjugated silica nanoparticles for photodynamic therapy and bioimaging.

Sobhanan J, Ono K, Okamoto T, Sawada M, Weiss P, Biju V Chem Sci. 2024; 15(6):2007-2018.

PMID: 38332815 PMC: 10848760. DOI: 10.1039/d3sc03877g.


Magnetic Fluorescent Quantum Dots Nanocomposites in Food Contaminants Analysis: Current Challenges and Opportunities.

Xiong J, Zhang H, Qin L, Zhang S, Cao J, Jiang H Int J Mol Sci. 2022; 23(8).

PMID: 35456904 PMC: 9028821. DOI: 10.3390/ijms23084088.


Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Weinstain R, Slanina T, Kand D, Klan P Chem Rev. 2020; 120(24):13135-13272.

PMID: 33125209 PMC: 7833475. DOI: 10.1021/acs.chemrev.0c00663.